Search Results - Duma, Viktor

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Interim-PET As a Predictive Factor in Patients with Hodgkin's Lymphoma

    Interim-PET As a Predictive Factor in Patients with Hodgkin's Lymphoma by Kryachok, Irina, Novosad, Olga, Pastushenko, Ian, Skrypets, Tetiana, Kadnikova, Tetiana, Tytorenko, Iryna, Kushchevyy, Evgen, Ulianchenko, Kateryna, Filonenko, Kateryna, Stepanishyna, Yana, Aleksik, Olena, Kmetyuk, Yaroslav, Karpova, Olga, Mykhalska, Larisa, Kindrakevych, Olga, Pylypenko, Halyna, Lukjanec, Olena, Duma, Viktor, Kozlov, Viktor, Batyuk, Liliya, Ryzhak, Olena, Strembitska, Nataliia, Chikalova, Hanna, Chupryna, Myroslava, Kozlov, Iurii, Novikov, Mykola, Kosinova, Viktoriia, Oliinichenko, Olena, Lola, Olena, Kholodna, Alina, Loza, Olga, Kostiukova, Nina, Tkachenko, Oksana, Karnabeda, Oksana, Stratienko, Viktoriya, Gorbach, Oleksandr, Danilov, Alexey

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Altered spreading of neuronal avalanches in temporal lobe epilepsy relates to cognitive performance: A resting‐state hdEEG study

    Altered spreading of neuronal avalanches in temporal lobe epilepsy relates to cognitive performance: A resting‐state hdEEG study by Duma, Gian Marco, Danieli, Alberto, Mento, Giovanni, Vitale, Valerio, Opipari, Raffaella Scotto, Jirsa, Viktor, Bonanni, Paolo, Sorrentino, Pierpaolo

    Published in Epilepsia (Copenhagen)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

    New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)... by Bolli, G. B., Riddle, M. C., Bergenstal, R. M., Ziemen, M., Sestakauskas, K., Goyeau, H., Home, P. D.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo by Bentley-Lewis, Rhonda, MD, Aguilar, David, MD, Riddle, Matthew C., MD, Claggett, Brian, PhD, Diaz, Rafael, MD, Dickstein, Kenneth, MD, PhD, Gerstein, Hertzel C., MD, Johnston, Peter, MD, Køber, Lars V., MD, Lawson, Francesca, MD, Lewis, Eldrin F., MD, Maggioni, Aldo P., MD, McMurray, John J.V., MD, Ping, Lin, MD, Probstfield, Jeffrey L., MD, Solomon, Scott D., MD, Tardif, Jean-Claude, MD, Wu, Yujun, PhD, Pfeffer, Marc A., MD, PhD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Hydroxyurea Associated Cutaneous Lesions: A Case Report

    Hydroxyurea Associated Cutaneous Lesions: A Case Report by Simeonovski, Viktor, Breshkovska, Hristina, Duma, Silvija, Dohcheva-Karajovanov, Ivana, Damevska, Katerina, Nikolovska, Suzana

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Hydroxyurea Associated Cutaneous Lesions: A Case Report

    Hydroxyurea Associated Cutaneous Lesions: A Case Report by Simeonovski, Viktor, Breshkovska, Hristina, Duma, Silvija, Dohcheva-Karajovanov, Ivana, Damevska, Katerina, Nikolovska, Suzana

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: